Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation

Blood

Volumn 94, Issue 1, 1999, Pages 333-339

  Ruggeri, Loredana ^b   Capanni, Marusca ^b   Casucci, Myriam ^b   Volpi, Isabella ^b   Tosti, Antonella ^b   Perruccio, Katia ^b   Urbani, Elena ^b   Negrin, Robert S ^b   Martelli, Massimo F ^b   Velardi, Andrea ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CHRONIC MYELOID LEUKEMIA; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; IMMUNOPATHOGENESIS; LYMPHOCYTE ACTIVATION; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033168770     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.1.333.413a31_333_339     Document Type: Article

References (33)

1. Moretta A, Moretta L: HLA class I specific inhibitory receptors. Curr Opin Immunol 9:694, 1997
2. Lanier LL: NK cell receptors. Annu Rev Immunol 16:359, 1998
3. Braud VM, Allan DS, O'Callaghan CA, Soderstrom K, D'Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL, McMichael AJ: HLA-E binds to natural killer cell receptors CD94/ NKG2A, B and C. Nature 391:795, 1998
4. Lee N, Liano M, Carretero M, Ishitani A, Navarro F, Lopez-Botet M, Geraghty DE: HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci USA 95:5199, 1998
5. Wagtmann N, Biassoni R, Cantoni C, Verdiani S, Malnati M, Vitale M, Bottino C, Moretta L, Moretta A, Long EO: Molecular clones of the p58 natural killer cell receptor reveal Ig-related molecules with diversity in both the extra-and intra-cellular domains. Immunity 2:439, 1995
6. Colonna M, Samaridis J: Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 268:405, 1995
7. D'andrea A, Chang C, Franz-Bacon K, McClanahan T, Phillips JH, Lanier LL: Molecular cloning of NKB1: A natural killer cell receptor for HLA-B allotypes. J Immunol 155:2306, 1995
8. Pende D, Biassoni R, Cantoni C, Verdiani S, Falco M, di Donato C, Accame L, Bottino C, Moretta A, Moretta L: The natural killer cell receptor specific for HLA-A allotypes: A novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer J Exp Med 184:505, 1996
9. Uhrberg M, Valiante NM, Shum BP, Shilling HG, Lienert-Weidenbach K, Corliss B, Tyan D, Lanier LL, Parham P: Human diversity in killer cell inhibitory receptors genes. Immunity 7:753, 1997
10. Ciccone E, Viale O, Pende D, Malnati M, Biassoni R, Melioli G, Moretta A, Long EO, Moretta L: Specific lysis of allogeneic cells after activation of CD3-lymphocytes in mixed lymphocyte culture. J Exp Med 168:2403, 1988
11. Ciccone E, Pende D, Viale O, Tambussi G, Ferrini S, Biassoni R, Longo A, Guardiola J, Moretta A, Moretta L: Specific recognition of human CD3-/CD16+ natural killer cells requires the expression of an autosomic recessive gene on target cells. J Exp Med 172:47, 1990
12. Ciccone E, Colonna M, Viale O, Pende D, Di Donato C, Reinharz D, Amoroso A, Jeannet M, Guardiola J, Moretta A, Spies T, Strominger JL, Moretta L: Susceptibility or resistance to lysis by alloreactive natural killer cells is governed by a gene in the human major histocompatibility complex between BF and HLA-B. Proc Natl Acad Sci USA 87:9794, 1990
13. Ciccone E, Pende D, Viale O, Di Donato C, Tripodi G, Orengo AM, Guardiola J, Moretta A, Moretta L: Evidence of a killer (NK) cell repertoire for (allo) antigen recognition: Definition of five distinct NK-determined allospecificities in humans. J Exp Med 175:709, 1992
14. Ciccone E, Pende D, Viale O, Di Donato C, Orengo AM, Biassoni R, Verdiani S, Amoroso A, Moretta A, Moretta L: Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: Expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2). J Exp Med 176:963, 1992
15. Colonna M, Spies T, Strominger JL, Ciccone E, Moretta A, Moretta L, Pende D, Viale O: Alloantigen recognition by two human natural killer cell clones is associated with HLA-C or a closely linked gene. Proc Natl Acad Sci USA 89:7983, 1992
16. Colonna M, Brooks EG, Falco M, Ferrara GB, Strominger JL: Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C. Science 260:1121, 1993
17. Colonna M, Borsellino G, Falco M, Ferrara GB, Strominger JL: HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1-and NK2-specific natural killer cells. Proc Natl Acad Sci USA 90:1200, 1993
18. Aversa F, TabilioA, Terenzi A, VelardiA, Falzetti F, Giannoni C, Jacucci R, Zei T, Martelli MP, Gambelunghe C, Rossetti M, Caputo P, Latini P, Aristei C, Raymondi C, Reisner Y, Martelli MF: Successful engrafment of T-cell-depleted haploidentical, "three loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 84:3948, 1994
19. Aversa F, Tabilio A, Velardi A, Cunningham I, Terenzi A, Falzetti F, Ruggeri L, Barbabietola G, Aristei C, Latini P, Reisner Y, Martelli MF: Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med 339:1186, 1998
20. + T cells expressing NK receptors for MHC class I after "three-loci" HLA-incompatible bone marrow transplantation. Blood 87:3993, 1996
21. Laver J, Jhanavar SC, O'Reilly RJ, Castro-Malaspina: Host origin of the human hematopoietic microenvironment following allogeneic bone marrow transplantation. Blood 70:1966, 1987
22. Vitale M, Sivori S, Pende D, Agugliaro R, Di Donato C, Amoroso A, Malnati M, Bottino C, Moretta L, Moretta A: Physical and functional independency of p70 and p58 natural killer (NK) cell receptors for HLA class I: Their role in the definition of different groups of alloreactive NK cell clones. Proc Natl Acad Sci USA 93:1453, 1996
23. Biassoni R, Falco M, Cambiaggi A, Costa P, Verdiani S, Pende D, Conte R, Di Donato C, Parham P, Moretta L: Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1 " NK clones. J Exp Med 182:605, 1995
24. Sykes M, Harty MW, Karlhofer FM, Pearson DA, Szot G, Yokoyama W: Hematopoietic cells and radioresistant host elements influence natural killer cell differentiation. J Exp Med 178:223, 1993
25. Salcedo M, Andersson M, Lemieux S, Van Kaer L, Chambers BJ, Ljunggren HG: Fine tuning of natural killer cell specificity and maintenance of self tolerance in MHC class I-deficient mice. Eur J Immunol 28:1315, 1998
26. Yu YYL, Kumar V, Bennett M: Murine natural killer cells and marrow graft rejection. Annu Rev Immunol 10:189, 1992
27. Galandrini R, Albi N, Zarcone D, Grossi CE, Velardi A: Adhesion molecule-mediated signals regulate MHC-unrestricted and CD3/TCR-triggered cytotoxicity. Eur J Immunol 22:2047, 1992
28. Hauch M, Gazzola MV, Small T, Bordignon C, Barnett L, Cunningham I, Castro-Malaspina H, O'Reilly RJ, Keever CA: Anti-leukemia potential of interleukin-2-activated natural killer cells after bone marrow transplantation for chronic myelogenous leukemia. Blood 75:2250, 1990
29. Cervantes F, Pierson BA, McGlave PB, Verfaillie CM, Miller JS: Autologous activated natural killer cells suppress primitive chronic myelogenous leukemia progenitors in long-term culture. Blood 87: 2476, 1996
30. Uharek L, Glass B, Gaska T, Zeiss M, Gassmann W, Loeffler H, Mueller-Ruchholtz W: Natural killer cells as effector cells of graft-versus-leukemia activity in a murine transplantation model. Bone Marrow Transplant 12:857, 1993 (suppl)
31. Glass B, Uharek L, Zeis M, Loeffler H, Mueller-Ruchholtz, Gassmann W: Graft-versus-leukemia activity can be predicted by natural cytotoxicity against leukemia cells. Br J Haematol 93:412, 1996
32. Zeis M, Uharek L, Lass B, Steinmann J, Dreger P, Gassmann W, Schmitz N: Allogeneic MHC-mismatched activated natural killer cells administered after bone marrow transplantation provide a strong graft-versus-leukemia effect in mice. Br J Haematol 96:757, 1997
33. Asai O, Longo DL, Tian Z, Hornung RL, Taub DD, Ruscetti FW, Murphy WJ: Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation. J Clin Invest 101:1835, 1998